MedTrace Logo

Gout Self-Monitoring Aiming to Reach Target

NCT03274063 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2024-05-21

Study results available
· View outcomes & findings →

Summary

This study evaluates whether a supported self-management approach to gout is able to achieve target levels of serum urate, and better control of gout flares.

Conditions

Interventions

OTHER

Supported self-management

Participants will be supplied with urate self-testing kits. Participants will have a mobile phone application installed which will prompt the participant to perform urate self-testing, enable the clinical research team to advise on escalation of urate lowering therapy, and collect quality of life data .

OTHER

Usual care

Participants will have a mobile phone application installed which will allow the research team to collect quality of life data.

Sponsors & Collaborators

  • University of Edinburgh

    lead OTHER

Principal Investigators

  • Philip L Riches, FRCP PhD · University of Edinburgh/NHS Lothian

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-05
Primary Completion
2021-03-19
Completion
2021-06-01

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03274063 on ClinicalTrials.gov